Buchumschlag

Curtailment in single-arm two-stage phase II oncology trials

Two-stage designs that allow for early stopping if the treatment is ineffective are commonly used in phase II oncology trials. A limitation of current designs is that early stopping is only allowed at the end of the first stage, even if it becomes evident during the trial that a significant result i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kunz, Cornelia Ursula (VerfasserIn) , Kieser, Meinhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 2012
In: Biometrical journal
Year: 2012, Jahrgang: 54, Heft: 4, Pages: 445-456
ISSN:1521-4036
DOI:10.1002/bimj.201100128
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/bimj.201100128
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/bimj.201100128
Volltext
Verfasserangaben:Cornelia U. Kunz and Meinhard Kieser

MARC

LEADER 00000caa a2200000 c 4500
001 1582596271
003 DE-627
005 20220815045748.0
007 cr uuu---uuuuu
008 181106s2012 xx |||||o 00| ||eng c
024 7 |a 10.1002/bimj.201100128  |2 doi 
035 |a (DE-627)1582596271 
035 |a (DE-576)512596271 
035 |a (DE-599)BSZ512596271 
035 |a (OCoLC)1341022069 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kunz, Cornelia Ursula  |d 1979-  |e VerfasserIn  |0 (DE-588)1024218112  |0 (DE-627)719391911  |0 (DE-576)368162435  |4 aut 
245 1 0 |a Curtailment in single-arm two-stage phase II oncology trials  |c Cornelia U. Kunz and Meinhard Kieser 
264 1 |c July 2012 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.11.2018 
520 |a Two-stage designs that allow for early stopping if the treatment is ineffective are commonly used in phase II oncology trials. A limitation of current designs is that early stopping is only allowed at the end of the first stage, even if it becomes evident during the trial that a significant result is unlikely. One way to overcome this limitation is to implement stochastic curtailment procedures that enable stopping the trial whenever the conditional power is below a pre-specified threshold θ. In this paper, we present the results for implementing curtailment rules in either only the second stage or both stages of the designs. In total, 102 scenarios with different parameter settings were investigated using conditional power thresholds θ between 0 and 1 in steps of 0.01. An increase in θ results not only in a decrease of the actual Type I error rate and power but also of the expected sample size. Therefore, a reasonable balance has to be found when selecting a specific threshold value in the planning phase of a curtailed two-stage design. Given that the effect of curtailment highly depends on the underlying design parameters, no general recommendation for θ can be made. However, up to , the loss in power was less than 5% for all investigated scenarios while savings of up to 50% in expected sample size occurred. In general, curtailment is most appropriate when the outcome can be observed fast or when accrual is slow so that adequate information for making early and frequent decisions is available. 
650 4 |a Conditional power 
650 4 |a Curtailment 
650 4 |a Phase II 
650 4 |a Simon's two-stage design 
700 1 |a Kieser, Meinhard  |d 1960-  |e VerfasserIn  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 aut 
773 0 8 |i Enthalten in  |t Biometrical journal  |d Berlin : Wiley-VCH, 1977  |g 54(2012), 4, Seite 445-456  |h Online-Ressource  |w (DE-627)271350229  |w (DE-600)1479920-0  |w (DE-576)078590868  |x 1521-4036  |7 nnas  |a Curtailment in single-arm two-stage phase II oncology trials 
773 1 8 |g volume:54  |g year:2012  |g number:4  |g pages:445-456  |g extent:12  |a Curtailment in single-arm two-stage phase II oncology trials 
856 4 0 |u http://dx.doi.org/10.1002/bimj.201100128  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/bimj.201100128  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181106 
993 |a Article 
994 |a 2012 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 999701  |e 910000PK103276547X  |e 999701PK103276547X  |k 0/910000/  |k 1/910000/999701/  |p 2  |y j 
998 |g 1024218112  |a Kunz, Cornelia Ursula  |m 1024218112:Kunz, Cornelia Ursula  |d 50000  |e 50000PK1024218112  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1582596271  |e 3030468364 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Cornelia Ursula","display":"Kunz, Cornelia Ursula","family":"Kunz"},{"family":"Kieser","display":"Kieser, Meinhard","given":"Meinhard","role":"aut"}],"note":["Gesehen am 06.11.2018"],"origin":[{"dateIssuedDisp":"July 2012","dateIssuedKey":"2012"}],"title":[{"title_sort":"Curtailment in single-arm two-stage phase II oncology trials","title":"Curtailment in single-arm two-stage phase II oncology trials"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["Cornelia U. Kunz and Meinhard Kieser"]},"recId":"1582596271","id":{"doi":["10.1002/bimj.201100128"],"eki":["1582596271"]},"relHost":[{"disp":"Curtailment in single-arm two-stage phase II oncology trialsBiometrical journal","language":["eng","ger"],"part":{"volume":"54","extent":"12","pages":"445-456","text":"54(2012), 4, Seite 445-456","year":"2012","issue":"4"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 17.04.07"],"origin":[{"dateIssuedKey":"1977","publisher":"Wiley-VCH","publisherPlace":"Berlin","dateIssuedDisp":"1977-"}],"title":[{"title":"Biometrical journal","title_sort":"Biometrical journal"}],"recId":"271350229","pubHistory":["Volume 19, issue 1 (1977)-"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"doi":["10.1002/(ISSN)1521-4036"],"issn":["1521-4036"],"eki":["271350229"],"zdb":["1479920-0"]}}]} 
SRT |a KUNZCORNELCURTAILMEN2012 

Ähnliche Einträge